ArticleVeterinary and comparative oncology2020

Rabacfosadine for naïve canine intermediate to large cell lymphoma: Efficacy and adverse event profile across three prospective clinical trials.

Corey F Saba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.